vimarsana.com

Latest Breaking News On - Geoff obrien - Page 1 : vimarsana.com

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) - MediciNova (NASDAQ:MNOV)

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.